Can be used to prevent or treat common colds and recurrent viral infections, skin aging and wrinkles, fatigue, Vitamin C deficiency and fibromyalgia
Both formulations remain in active distribution as of 2024
The body of evidence across multiple studies in various countries is conclusive that treatment with GLP-1 medications for type 2 diabetes and/or overweight/obesity is strongly associated with an elevated risk of developing NAION
However, a 2025 study found that people who used weight-loss medication regained weight more rapidly, with an average monthly weight regain of 0.4kg compared with 0.1kg in those who followed behavioural weight management programmes
How is Microdosing different from Compounded Tirzepatide use
The characteristics of the 60 cases are provided in Supplementary Table 8, and generally follow relevant prevalence trends in the test set